Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:421-424 (23 February), doi:10.1136/bmj.39470.505556.80
Allyson M Pollock, professor of international public health policy, Sylvia Godden, senior research fellow
1 Centre for International Public Health, University of Edinburgh, Edinburgh EH8 9AG
Correspondence to: A M Pollock allyson.pollock@ed.ac.uk
The government plans to continue using NHS funds to contract with commercial healthcare providers in the second phase of the independent sector treatment centre programme, but Allyson M Pollock and Sylvia Godden argue that no good evidence is available to support this policy
| The first 150 words of the full text of this article appear below. |
|
The policy of the Department of Health in England is to use NHS funds to contract with for-profit multinational healthcare corporations to deliver clinical services. One controversial aspect of this policy is the independent sector treatment centre programme, which over the course of two phases (waves) will provide elective surgery and other services at a total cost of over £5bn
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses